Home / Resources / Videos / ADA 2017 / Current Interview: Keith Campbell

Current Interview: Keith Campbell

Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from ADA 2017.

keith_campbellR. Keith Campbell, RPh, MBA, CDE, FASHP, FAPhA, FAADE, is the former Associate Dean and is the Distinguished Professor in Diabetes Care/Pharmacotherapy at the Washington State University College of Pharmacy in Pullman, Washington, where he has been a member of the faculty since 1968. A Professor Emeritus, Keith was recently honored by for the Lifetime Achievement Award during the Crimson Gala held at WSU. Proceeds from the event  contributed to naming the R. Keith Campbell Applied Patient Care Lab in the Pharmaceutical and Biomedical Sciences Building on the WSU Health Sciences campus in Spokane.


Keith is distinguished as being one of the first pharmacists to become a CDE (Certified Diabetes Educator) and has encouraged 100’s of pharmacists to become certified as CDE’s. Keith has truly changed the way pharmacists practice pharmacy. He is an active diabetes educator and is involved in numerous diabetes-related activities. He was a member of professional panels that wrote the position statements on Blood Glucose Monitoring for both ADA and AADE and assisted the NIH in translating the famous Diabetes Control and Complications Trial to try to change the treatment objectives of diabetes patients. He has a personal interest in diabetes having had type 1 diabetes for over 61 years. He has used an insulin pump for over 32 years.

Featured videos include:

Pt.1: Introduction and Background

Pt.2: The Biggest Advancements in Diabetes Care

Pt.3: New Drugs for Treating Diabetes

Pt.4: Diagnosing the Best Drug Treatment for Diabetes Patients

Pt.5: Being Empathetic to Diabetes Care

Pt.6: The Cure for Diabetes

or view the complete interview here: Complete Interview.

To read the transcript of the full interview, click here.